Upstream Bio, Inc. (UPB)
Healthcare
Biotechnology
—
6.30 $
-4.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Upstream Bio, Inc. (UPB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -48 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.8 | -16 | -18 | -8.0 | -14 | -20 | -41 | -39 | -22 | -31 | -48 | -140 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.8 | 5.9 | -0.7 | 2.4 | |
| 0.7 | 0.8 | 0.6 | 1.4 | 1.9 | 2.1 | 2.6 | 2.6 | 2.6 | 2.5 | 4.6 | 12 | |
| 3.1 | -4.0 | -3.9 | 6.3 | 0.7 | -1.3 | -15 | -1.1 | 8.9 | 7.7 | -11 | 4.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 12 | -5.2 | 14 | -117 | 1.4 | 42 | -213 | 13 | 48 | 59 | 42 | 162 | |
| 0.1 | -0.1 | 9.4 | 141 | -1.6 | 271 | 0.0 | 0.6 | 0.8 | 1.1 | 0.6 | 3.1 | |
| 7.5 | -21 | 5.7 | 16 | -14 | 293 | -255 | -26 | 27 | 29 | -4.9 | 25 | |
| -4.8 | -16 | -18 | -8.0 | -14 | -20 | -41 | -39 | -22 | -31 | -48 | -140 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.